Optical coherence tomography and vessel diameter changes after intravitreal bevacizumab in diabetic macular oedema.

@article{Soliman2008OpticalCT,
  title={Optical coherence tomography and vessel diameter changes after intravitreal bevacizumab in diabetic macular oedema.},
  author={Wael Soliman and Martin Vinten and Birgit Agnes Sander and Kamell Abd El-Naser Soliman and Sameer Yehya and Mohamed Saad Abdel Rahman and Michael Larsen},
  journal={Acta ophthalmologica},
  year={2008},
  volume={86 4},
  pages={365-71}
}
PURPOSE To assess the effect of intravitreal bevacizumab on diabetic macular oedema (DMO) and retinal vessel calibres. METHODS We performed a consecutive case series study in which 10 consecutive eyes with diffuse DMO, two of which had not previously been treated, received an intravitreal injection of bevacizumab 1 mg, which was followed by two more injections at 6-week intervals. Fundus photography and optical coherence tomography (OCT) were carried out at baseline immediately before… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 32 extracted citations

Similar Papers

Loading similar papers…